European cardiomyopathy pilot registry: EURObservational research programme of the European society of cardiology

European Heart Journal

Volumn 37, Issue 2, 2016, Pages 164-173

  Elliott, Perry ^a   Charron, Philippe ^b   Blanes, Juan Ramon Gimeno ^c   Tavazzi, Luigi ^d   Tendera, Michal ^e   Konté, Marème ^f   Laroche, Cécile ^f   Maggioni, Aldo P ^f   Anastasakis, Aris ^g   Arbustini, Eloisa ^h   Asselbergs, Folkert W ⁱ   Axelsson, Anna ^j   Brito, Dulce ^k   Caforio, Alida L P ^l   Carr White, Gerald ^m   Czekaj, Agata ^e   Damy, Thibaud ⁿ   Devoto, Emmanuela ^o   Favalli, Valentina ^h   Findlay, Iain ^p   Garcia Pavia, Pablo ^q   Hagège, Albert ^r   Heliö, Tiina ^s   Iliceto, Sabino ^l   Isnard, Richard ^b   Jansweijer, Joeri A ^t   Limongelli, Giuseppe ^u   Linhart, Ales ^v   Cuenca, David López ^c   Mansencal, Nicolas ^w   McKeown, Pascal ^x   Mogensen, Jens ^y   Mohiddin, Saidi A ^z   Monserrat, Lorenzo ^aa   Olivotto, Iacopo ^ab   Rapezzi, Claudio ^ac   Rigopoulos, A G ^ad   Rosmini, Stefania ^a   Pfeiffer, Barbara ^ad   Wicks, Eleanor ^a   Podzimkova, J ^v   Kuchynka, P ^v   Palecek, T ^v   Bundgaard, H ^ae   Thune, J J ^ae   Kumme, A ^y   Due Vestergaard, L ^y   Hey, T ^y   Ollila, L ^af   Kaartinen, M ^af   Dubourg, O ^w   Arslan, M ^w   Siam Tsieu, M ^w   Guellich, A ⁿ   Tissot, C M ⁿ   Guendouz, S ⁿ   Thevenin, S ^r   Cheikh Khelifa, R ^b   Gandjbakhch, E ^b   Komajda, M ^b   Neugebauer, A ^ad   Pfeiffer, B ^ad   Steriotis, A ^ag   Ritsatos, K ^ag   Vlagkouli, V ^ag   Biagini, E ^ac   Gentile, N ^ac   Longhi, S ^ac   Arretini, A ^ah   Fornaro, A ^ah   Cecchi, F ^ah   Spirito, P ^o   Formisano, F ^o   Masarone, D ^ai   Valente, F ^ai   Pacileo, G ^ai   Schiavo, A ^l   Testolina, M ^l   Serio, A ^h   Grasso, M ^h   Wilde, A ^t   Pinto, Y ^t   Klopping C ⁱ   Van Der Heijden, J F ⁱ   De Jonge, N ⁱ   Sikora Puz, A ^e   Wybraniec, M ^e   Czekaj, A ^e   Francisco, A R ^aj   Brito, D ^aj   Madeira, H ^aj   Ortiz Genga, M ^aa   Barriales Villa, R ^aa   Fernandez, X ^aa   Lopez Cuenca, D ^c   Gomez Milanes, I ^c   Lopez Ayala, J M ^c   Guzzo Merello, G ^q   Gallego Delgado, M ^q   Muir, A ^x   McOsker, J ^x   Jardine, T ^x   Iqbal, H ^z   Sekhri, N ^z   Rajani, R ^ak   Bueser, T ^ak   Watkinson, O ^al   more..

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^d MARIA CECILIA HOSPITAL   (Italy)

^e MEDICAL UNIVERSITY OF SILESIA   (Poland)

^f European Society of Cardiology   (France)

^g UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^h FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

ⁱ UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^j Rigshospitalet   (Denmark)

^k INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^l UNIVERSITY OF PADOVA   (Italy)

^m GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

ⁿ HENRI MONDOR HOSPITAL   (France)

^o GALLIERA HOSPITAL   (Italy)

^p ROYAL ALEXANDRA HOSPITAL   (United Kingdom)

^q HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^r HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^s UNIVERSITY OF HELSINKI   (Finland)

^t ACADEMIC MEDICAL CENTER   (Netherlands)

^u SECOND UNIVERSITY OF NAPLES   (Italy)

^v CHARLES UNIVERSITY   (Czech Republic)

^w HÔPITAL AMBROISE PARÉ   (France)

^x ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^y ODENSE UNIVERSITY HOSPITAL   (Denmark)

^z LONDON CHEST HOSPITAL   (United Kingdom)

^aa HOSPITAL JUAN CANALEJO   (Spain)

^ab CAREGGI UNIVERSITY HOSPITAL   (Italy)

^ac UNIVERSITY OF BOLOGNA   (Italy)

^ad Leopoldina Krankenhaus   (Germany)

^ae Mental Health Center Glostrup   (Denmark)

^af HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^ag IASO GENERAL HOSPITAL   (Greece)

^ah UNIVERSITY OF FLORENCE   (Italy)

^ai MONALDI HOSPITAL   (Italy)

^aj UNIVERSITY OF LISBON   (Portugal)

^ak ST THOMAS HOSPITAL   (United Kingdom)

^al UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

more..

Author keywords

Arrhythmogenic right ventricular; Cardiomyopathy; Dilated; Hypertrophic; Registry; Restrictive

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; MINERALOCORTICOID ANTAGONIST; CARDIOTONIC AGENT;

ADULT; AMYLOIDOSIS; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOLOGY; CARDIOVASCULAR MAGNETIC RESONANCE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DANON DISEASE; DIAGNOSTIC TEST; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTROCARDIOGRAPHY MONITORING; EUROPE; EXERCISE TEST; FABRY DISEASE; FAINTNESS; FAMILIAL DISEASE; FAMILY HISTORY; FEMALE; FOLLOW UP; GENETIC SCREENING; GEOGRAPHIC DISTRIBUTION; HEART MUSCLE BIOPSY; HEART RIGHT VENTRICLE DYSPLASIA; HUMAN; HUMAN TISSUE; HYPERTROPHIC CARDIOMYOPATHY; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LEOPARD SYNDROME; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; NEW YORK HEART ASSOCIATION CLASS; NOONAN SYNDROME; PHENOTYPE; PRIORITY JOURNAL; RARE DISEASE; REGISTER; RESTRICTIVE CARDIOMYOPATHY; SUDDEN CARDIAC DEATH; TRANSTHORACIC ECHOCARDIOGRAPHY; VENTRICULAR NONCOMPACTION; AGE DISTRIBUTION; ARTIFICIAL HEART PACEMAKER; CARDIOMYOPATHIES; CLINICAL TRIAL; DEATH, SUDDEN, CARDIAC; DEFIBRILLATOR; DEMOGRAPHY; MIDDLE AGED; MULTICENTER STUDY; ONSET AGE; PILOT STUDY; SEX RATIO; STATISTICS AND NUMERICAL DATA;

ADULT; AGE DISTRIBUTION; AGE OF ONSET; CARDIOMYOPATHIES; CARDIOTONIC AGENTS; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; PILOT PROJECTS; REGISTRIES; RESIDENCE CHARACTERISTICS; SEX DISTRIBUTION;

EID: 84964575491     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehv497     Document Type: Article

References (24)

1. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kühl U, Maisch B, McKenna WJ, Monserrat L, Pankuweit S, Rapezzi C, Seferovic P, Tavazzi L, Keren A. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008;29:270-276.
2. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB; American Heart Association; Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; Council on Epidemiology and Prevention. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006;113:1807-1816.
3. Semsarian C, Ingles J, Maron MS, Maron BJ. New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol 2015;65:1249-1254.
4. Rakar S, Sinagra G, Di Lenarda A, Poletti A, Bussani R, Silvestri F, Camerini F. Epidemiology of dilated cardiomyopathy. A prospective post-mortem study of 5252 necropsies. The Heart Muscle Disease Study Group. Eur Heart J 1997;18:117-123.
5. Basso C, Corrado D, Thiene G. Cardiovascular causes of sudden death in young individuals including athletes. Cardiol Rev 1999;7:127-135.
6. Tabib A, Loire R, Chalabreysse L, Meyronnet D, Miras A, Malicier D, Thivolet F, Chevalier P, Bouvagnet P. Circumstances of death and gross and microscopic observations in a series of 200 cases of sudden death associated with arrhythmogenic right ventricular cardiomyopathy and/or dysplasia. Circulation 2003;108:3000-3005.
7. Wellens HJ, Schwartz PJ, Lindemans FW, Buxton AE, Goldberger JJ, Hohnloser SH, Huikuri HV, Kääb S, La Rovere MT, Malik M, Myerburg RJ, Simoons ML, Swedberg K, Tijssen J, Voors AA, Wilde AA. Risk stratification for sudden cardiac death: current status and challenges for the future. Eur Heart J 2014;35:1642-1651.
8. Hayashi M, Shimizu W, Albert CM. The spectrum of epidemiology underlying sudden cardiac death. Circ Res 2015;116:1887-1906.
9. Authors/Task Force Members, Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege AA, Lafont A, Limongelli G, Mahrholdt H, McKenna WJ, Mogensen J, Nihoyannopoulos P, Nistri S, Pieper PG, Pieske B, Rapezzi C, Rutten FH, Tillmanns C, Watkins H. 2014 ESC Guidelines on Diagnosis and Management of Hypertrophic Cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014;35:2733-2779.
10. Tavazzi L. CardioPulse articles: update on the ESC EURObservational research programme. Eur Heart J 2010;31:1023-1031.
11. Kohli SK, Pantazis AA, Shah JS, Adeyemi B, Jackson G, McKenna WJ, Sharma S, Elliott PM. Diagnosis of left-ventricular non-compaction in patients with leftventricular systolic dysfunction: time for a reappraisal of diagnostic criteria? Eur Heart J 2008;29:89-95.
12. Alfares AA, Kelly MA, McDermott G, Funke BH, Lebo MS, Baxter SB, Shen J, McLaughlin HM, Clark EH, Babb LJ, Cox SW, DePalma SR, Ho CY, Seidman JG, Seidman CE, Rehm HL. Results of clinical genetic testing of 2, 912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity. Genet Med 2015; doi:10.1038/gim.2014.205.
13. Fressart V1, Duthoit G, Donal E, Probst V, Deharo JC, Chevalier P, Klug D, Dubourg O, Delacretaz E, Cosnay P, Scanu P, Extramiana F, Keller D, Hidden-Lucet F, Simon F, Bessirard V, Roux-Buisson N, Hebert JL, Azarine A, Casset-Senon D, Rouzet F, Lecarpentier Y, Fontaine G, Coirault C, Frank R, Hainque B, Charron P. Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: spectrum of mutations and clinical impact in practice. Europace 2010;12:861-868.
14. Harakalova M1, Kummeling G, Sammani A, Linschoten M, Baas AF, van der Smagt J, Doevendans PA, van Tintelen JP, Dooijes D, Mokry M, Asselbergs FW. A systematic analysis of genetic dilated cardiomyopathy reveals numerous ubiquitously expressed and muscle-specific genes. Eur J Heart Fail 2015;17:484-493.
15. Dubrey SW. Amyloid heart disease: a brief review of treatment options. Postgrad Med J 2012;88:700-705.
16. Ruberg FL, Berk JL. Transthyretin (TTR) cardiac amyloidosis. Circulation 2012;126:1286-1300.
17. Meyer S, van der Meer P, van Tintelen JP, van den Berg MP. Sex differences in cardiomyopathies. Eur J Heart Fail 2014;16:238-247.
18. Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, Levine GN, Narula J, Starling RC, Towbin J, Virmani R. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. Eur Heart J 2007;28:3076-3093.
19. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A; Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P; ESC Committee for Practice Guidelines; ESC Committee for Practice Guidelines. ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012;14:803-869.
20. O'Mahony C, Jichi F, Pavlou M, Monserrat L, Anastasakis A, Rapezzi C, Biagini E, Gimeno JR, Limongelli G, McKenna WJ, Omar RZ, Elliott PM. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). Eur Heart J 2014;35:2010-2020.
21. Castelli G, Fornaro A, Ciaccheri M, Dolara A, Troiani V, Tomberli B, Olivotto I, Gensini GF. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management. Circ Heart Fail 2013;6:913-921.
22. Schinkel AF. Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications. Circ Arrhythm Electrophysiol 2013;6:562-568.
23. Nugent AW, Daubeney PE, Chondros P, Carlin JB, Cheung M, Wilkinson LC, Davis AM, Kahler SG, Chow CW, Wilkinson JL, Weintraub RG; National Australian Childhood Cardiomyopathy Study. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med 2003;348:1639-1646.
24. Lipshultz SE, Sleeper LA, Towbin JA, Lowe AM, Orav EJ, Cox GF, Lurie PR, McCoy KL, McDonald MA, Messere JE, Colan SD. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 2003;348:1647-1655.